According to a recent Health Affairs Perspective from Michael Chernew, the answer is ‘no’. In fact, physician and hospital prices may be too low. Although much has been made of high prices contributing to high spending in the US, 5 spending growth in Medicare is not driven by price growth. In fact, inflation-adjusted Medicare physician…
Positive Development’s Series C round was co-led by aMoon, B Capital and Flare Capital Partners, and included participation from Digitalis Ventures and Healthworx. The post Positive Development Rakes In $51.5M To Grow Developmental Therapy Model for Autism appeared first on MedCity News.
As public trust in the U.S. healthcare system declines, Intermountain Health CEO Rob Allen thinks that nonprofit hospitals can do a better job showcasing how they reinvest in their communities. He pointed to Intermountain’s work in areas like affordable housing, food access and charity care as examples of nonprofit providers’ often-overlooked value. The post Intermountain…
Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against upper respiratory tract infections. The post RFK Jr. Cancels $500M in mRNA R&D Contracts as HHS Turns Focus to Older, Slower Vaccine Technologies appeared first on…
The HHS Secretary has canceled contracting for the development of multiple vaccines
Company says the designation creates a nationwide on-ramp for interoperability and expands the types of data and organizations it can collaborate with
Accessia Health’s Tiara Green says her organization is providing financial assistance to help cover the cost of health screenings and diagnostic services
This analysis of initial rate filings from all 50 states and DC shows ACA Marketplace insurers are proposing a median premium increase of 18% for 2026, more than double last year’s 7% median proposed increase. The analysis includes proposed rate changes by state and insurer.
This near-constant level of unpredictability forces us to ask a tricky question: how can biopharma companies stay ahead? The answer, as to many of the tricky questions of our time, lies in having a clear and authentic mission to act as a guiding lighthouse in the turbulent waters of change. The post Maintaining Composure in…
Providers stand to gain a lot by making smart AI and automation decisions, but that value depends on investing in the right places. It may be tempting to plug in a single-point solution to fix an immediate challenge, but a more strategic, long-term approach will unlock greater value. The post Making AI Count: 3 Ways…